Gynecologic Cancer News

Individuals with cancer reported significantly reduced pain immediately following a 10-minute virtual reality (VR) session, study results published in Cancer showed.

The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki for the treatment of adults with unresectable or metastatic HER2-positive solid tumors who received previous systemic therapy and lack additional treatment options.

Clinicians treating patients with tumor-infiltrating lymphocytes should closely monitor toxicities associated with interleukin-2 and halt administration of the drug if necessary, according to the first guidelines regarding the therapy.

English proficiency, income and insurance type could factor into why women cared for at rural community health centers screen for cervical less than those who receive health care services at urban community health centers.

Most of the major cancer clinical trial centers in the U.S. are located near more affluent and white populations compared with the national average, according to results published in JAMA Oncology.

Individuals with elevated and worsening metabolic syndrome had an increased risk for developing an array of cancer types compared with those who did not, according to results published in Cancer.

Simple hysterectomy is not inferior to radical hysterectomy in terms of 3-year incidence of pelvic disease recurrence among women with low-risk cervical cancer, according to study data published in The New England Journal of Medicine.

Extended family members of men with severe subfertility or infertility may have an increased risk for several different cancer types, study results published in Human Reproduction showed.

More than 130,000 cancer cases went undiagnosed during the first 10 months of the COVID-19 pandemic, researchers estimated in a cross-sectional analysis published in JAMA Oncology.